Abiopharma

News list

Gallagher Duncan 🟢 acquired 5.0K shares of Health Catalyst, Inc. (HCAT) Transaction Date: Sep 01, 2025 | Filing ID: 006120

Full text

News bot Sept. 5, 2025, 8:54 p.m.
🔍 Gallagher Duncan (Executive)

Company: Health Catalyst, Inc. (HCAT)

Report Date: 2025-09-01
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 4,970
Detailed Transactions and Holdings:
- Acquired 4,970 shares of Common Stock (Direct)
  Date: 2025-09-01 | Code: A | equity_swap_involved: false | shares_owned_after: 118,252.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested on September 1, 2025.